SEC Form 4 · accession 0001140361-15-033656
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Serge Novovich
Director
Period of report
Aug 25, 2015
Accepted (ET)
Aug 27, 2015 · 6:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 25, 2015 | M | 4,375 | $1.29 | A | 4,375 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.29 | Aug 25, 2015 | M | 4,375 | D | — | Nov 18, 2022 | Common Stock | 4,375 | 13,125 | D |
Explanation of responses
- F1This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.